版本:
中国

BRIEF-Aralez Pharmaceuticals reports Q4 loss per share $0.48

March 13 Aralez Pharmaceuticals Inc

* Aralez reports fourth quarter and full-year 2016 financial results

* Qtrly net revenues increased to $20 million versus $6 million in comparable period of 2015

* Sees 2017 net revenues to be in a range of $80 million to $100 million

* Aralez Pharmaceuticals Inc qtrly loss per share $0.48

* Sees 2017 adjusted EBITDA to be in a range of a loss of $25 million to a loss of $10 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐